FDA’s Robyn Bent On The Evolution of Patient-Focused Drug Development

 
• By Brenda Sandburg

The director of the agency’s patient-focused drug development program talks to the Pink Sheet about how the program has improved the development and evaluation of new drugs, initiatives underway, and plans to standardize and harmonize the process.

PFDD decade
Director of US FDA's patient-focused drug development program talks about its accomplishments and future initiatives • Source: Shutterstock

More from Interviews

More from Pink Sheet